Crosstalk between cytokines and IgG N-Glycosylation: Bidirectional effects and relevance to clinical innovation for inflammatory diseases

Document Type

Journal Article

Publication Title

OMICS A Journal of Integrative Biology

Volume

28

Issue

12

First Page

608

Last Page

619

PubMed ID

39585210

Publisher

Mary Ann Liebert, Inc. Publishers

School

Centre for Precision Health / School of Medical and Health Sciences

RAS ID

77130

Funders

Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515012910) / Special Funds for Science and Technology of Guangdong Province (210715106900976, 210712096871576) / Western Australian Future Health Research and Innovation Fund (ID WANMA/Ideas2023-24/10)

Comments

Chen, Z., Xu, X., Song, M., & Lin, L. (2024). Crosstalk between cytokines and IgG N-Glycosylation: Bidirectional effects and relevance to clinical innovation for inflammatory diseases. OMICS: A Journal of Integrative Biology, 28(12), 608-619. https://doi.org/10.1089/omi.2024.0176

Abstract

The crosstalk between cytokines and immunoglobulin G (IgG) N-glycosylation forms a bidirectional regulatory network that significantly impacts inflammation and immune function. This review examines how various cytokines, both pro- and anti-inflammatory, modulate IgG N-glycosylation, shaping antibody activity and influencing inflammatory responses. In addition, we explore how altered IgG N-glycosylation patterns affect cytokine production and immune signaling, either promoting or reducing inflammation. Through a comprehensive analysis of current studies, this review underscores the dynamic relationship between cytokines and IgG N-glycosylation. These insights enhance our understanding of the mechanisms underlying inflammatory diseases and contribute to improved strategies for disease prevention, diagnosis, monitoring, prognosis, and the exploration of novel treatment options. By focusing on this crosstalk, we identify new avenues for developing innovative diagnostic tools and therapies to improve patient outcomes in inflammatory diseases.

DOI

10.1089/omi.2024.0176

Access Rights

subscription content

Link to Full Text

Share

 
COinS